RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS

      Prognosis after intrahepatic recurrence in the patients who underwent curative resection for hepatocellular carcinoma

      한글로보기

      https://www.riss.kr/link?id=A107145377

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Backgrounds/Aims: Intrahepatic recurrence is frequent result after hepatectomy for hepatocellular carcinoma (HCC). We analyzed the clinical results of patients who had the intrahepatic recurrences of HCC after curative surgical resections. Methods: Fr...

      Backgrounds/Aims: Intrahepatic recurrence is frequent result after hepatectomy for hepatocellular carcinoma (HCC). We analyzed the clinical results of patients who had the intrahepatic recurrences of HCC after curative surgical resections. Methods: From January 2009 to December 2016, 320 patients underwent curative surgical resection for HCC in department of Surgery, Korea Cancer Center Hospital. After surgical resection, 155 patients had suffered HCC recurrence during follow-up period. Among them, 122 patients had only intrahepatic recurrence initially, who were included in this retrospective study. We analyzed about the period of the recurrence after surgery, treatment methods for the recurred tumors, and poor prognostic factors for survival after intrahepatic recurrences. Results: Among the 122 patients, 83 patients had recurrence within 24 months after surgery. Thirty-eight patients underwent curative treatment for the recurred tumors (re-resection in 18, radiofrequency ablation in 20 patients). Non-curative treatments were performed in 77 patients (TACE in 68 patients, radiotherapy in 9 patients) and conservative management in 7 patients. Five-year survival rate of patients who underwent curative treatment is 86.4% (p≤0.001). Five-year survival rate of non-curative treatment is 55.7% (p≤0.001), conservative management is 0% (p=0.021). Among the clinical factors, non-curative treatment for recurred tumor, AFP level at the time of recurrence, size of recurred tumor were independent poor prognostic factors for survival after intrahepatic recurrences (p<0.001). Conclusions: For the patients who had intrahepatic recurrent HCC after surgery, aggressive local treatment can improve the prognosis in selective cases. Further study is necessary to validate this retrospective investigation.

      더보기

      목차 (Table of Contents)

      • INTRODUCTION
      • MATERIALS AND METHODS
      • RESULTS
      • DISCUSSION
      • REFERENCES
      • INTRODUCTION
      • MATERIALS AND METHODS
      • RESULTS
      • DISCUSSION
      • REFERENCES
      더보기

      참고문헌 (Reference)

      1 Livraghi T, "Treatment options in hepatocellular carcinoma today" 100 : 22-29, 2011

      2 Huang WY, "Stereotactic body radiation therapy in recurrent hepatocellular carcinoma" 84 : 355-361, 2012

      3 Hanazaki K, "Risk factors of intrahepatic recurrence after curative resection of hepatocellular carcinoma" 52 : 580-586, 2005

      4 Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy" 38 : 200-207, 2003

      5 Kew MC, "Recurrence of hepatocellular carcinoma after surgery : can it be avoided" 24 : 741-742, 1996

      6 Choi GH, "Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma" 15 : 618-629, 2008

      7 Kawano Y, "Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma : a retrospective study" 35 : 174-179, 2009

      8 Cha C, "Predictors and patterns of recurrence after resection of hepatocellular carcinoma" 197 : 753-758, 2003

      9 Matsumata T, "Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma" 9 : 457-460, 1989

      10 Notake T, "Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection" 22 : 715-725, 2017

      1 Livraghi T, "Treatment options in hepatocellular carcinoma today" 100 : 22-29, 2011

      2 Huang WY, "Stereotactic body radiation therapy in recurrent hepatocellular carcinoma" 84 : 355-361, 2012

      3 Hanazaki K, "Risk factors of intrahepatic recurrence after curative resection of hepatocellular carcinoma" 52 : 580-586, 2005

      4 Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy" 38 : 200-207, 2003

      5 Kew MC, "Recurrence of hepatocellular carcinoma after surgery : can it be avoided" 24 : 741-742, 1996

      6 Choi GH, "Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma" 15 : 618-629, 2008

      7 Kawano Y, "Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma : a retrospective study" 35 : 174-179, 2009

      8 Cha C, "Predictors and patterns of recurrence after resection of hepatocellular carcinoma" 197 : 753-758, 2003

      9 Matsumata T, "Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma" 9 : 457-460, 1989

      10 Notake T, "Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection" 22 : 715-725, 2017

      11 Poon RT, "Intrahepatic recurrence after curative resection of hepatocellular carcinoma : long-term results of treatment and prognostic factors" 229 : 216-222, 1999

      12 Taura K, "Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection : an analysis of 610 patients over 16 years old" 244 : 265-273, 2006

      13 Jang WI, "High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma" 8 : 250-, 2013

      14 Hirokawa F, "Appropriate treatment strategy for intrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma" 15 : 1182-1187, 2011

      15 Shimada K, "Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma" 14 : 2337-2347, 2007

      16 Umeda Y, "A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection" 35 : 170-177, 2011

      17 Jang WI, "A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma : safety and efficacy" 126 : 363-372, 2020

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2025 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2020-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼